WIA
UTHR icon

World Investment Advisors’s United Therapeutics UTHR Stock Holding History

World Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$562K Sell
948
-106
-10% -$52.8K 0.01% 925
2025
Q4 		$514K Sell
1,054
-1
-0.1% -$466 0.01% 920
2025
Q3 		$442K Sell
1,055
-338
-24% -$114K 0.01% 828
2025
Q2 		$400K Sell
1,393
-935
-40% -$279K 0.01% 805
2025
Q1 		$718K Buy
2,328
+1,029
+79% +$353K 0.02% 590
2024
Q4 		$458K Buy
1,299
+202
+18% +$74.2K 0.01% 685
2024
Q3 		$393K Buy
+1,097
New +$371K 0.01% 653

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

World Investment Advisors's UTHR Position: Q1 2026 in Review

World Investment Advisors reduced its United Therapeutics (UTHR) stake by 10% in Q1 2026, selling an estimated $52.8K and leaving 948 shares worth $562K. The position accounts for 0.01% of the portfolio, ranked #925.

World Investment Advisors first reported a position in UTHR in Q3 2024 and has held it in 7 quarters since. The position peaked at $718K in Q1 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • World Investment Advisors held 948 shares of United Therapeutics worth $562K as of Q1 2026.
  • World Investment Advisors sold 106 United Therapeutics shares in Q1 2026, an estimated $52.8K.
  • United Therapeutics made up 0.01% of World Investment Advisors's portfolio in Q1 2026, its #925 holding.
  • World Investment Advisors first reported a position in United Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • World Investment Advisors's United Therapeutics position peaked at $718K in Q1 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on World Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.